Zebrafish Models of Neurodevelopmental Disorders: Past, Present, and Future

被引:102
|
作者
Sakai, Catalina [1 ]
Ijaz, Sundas [1 ]
Hoffman, Ellen J. [1 ,2 ]
机构
[1] Yale Univ, Ctr Child Study, Program Neurogenet, Yale Sch Med, New Haven, CT 06520 USA
[2] Yale Univ, Dept Neurosci, Yale Sch Med, New Haven, CT 06520 USA
来源
基金
美国国家卫生研究院;
关键词
zebrafish; neurodevelopmental disorders; autism spectrum disorders; epilepsy; schizophrenia; model system; genetics; neural circuits; WHOLE-BRAIN ACTIVITY; AUTISM SPECTRUM DISORDER; TARGETED GENE DISRUPTION; DE-NOVO MUTATIONS; LOCOMOTOR-ACTIVITY; REVERSE GENETICS; GENOME-WIDE; KNOCK-IN; EPILEPSY; 16P11.2;
D O I
10.3389/fnmol.2018.00294
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Zebrafish are increasingly being utilized as a model system to investigate the function of the growing list of risk genes associated with neurodevelopmental disorders. This is due in large part to the unique features of zebrafish that make them an optimal system for this purpose, including rapid, external development of transparent embryos, which enable the direct visualization of the developing nervous system during early stages, large progenies, which provide considerable tractability for performing high-throughput pharmacological screens to identify small molecule suppressors of simple behavioral phenotypes, and ease of genetic manipulation, which has been greatly facilitated by the advent of CRISPR/Cas9 gene editing technologies. This review article focuses on studies that have harnessed these advantages of the zebrafish system for the functional analysis of genes that are strongly associated with the following neurodevelopmental disorders: autism spectrum disorders (ASD), epilepsy, intellectual disability (ID) and schizophrenia. We focus primarily on studies describing early morphological and behavioral phenotypes during embryonic and larval stages resulting from loss of risk gene function. We highlight insights into basic mechanisms of risk gene function gained from these studies as well as limitations of studies to date. Finally, we discuss advances in in vivo neural circuit imaging in zebrafish, which promise to transform research using the zebrafish model by illuminating novel circuit-level mechanisms with relevance to neurodevelopmental disorders.
引用
收藏
页数:18
相关论文
共 50 条
  • [31] Multiple Sclerosis and Demyelinating Disorders: Past, Present, and Future
    Bakirtzis, Christos
    Evangelopoulos, Maria Elephteria
    Grigoriadis, Nikolaos
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (18)
  • [32] Gene therapy for the hemoglobin disorders: Past, present, and future
    Persons, DA
    Nienhuis, AW
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (10) : 5022 - 5024
  • [33] Insomnia Disorders: Nosology and Classification Past Present, and Future
    Poon, Shi-Hui
    Quek, Shin-Yi
    Lee, Tih-Shih
    JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES, 2021, 33 (03) : 194 - 200
  • [34] European guidelines for personality disorders: past, present and future
    Simonsen, Sebastian
    Bateman, Anthony
    Bohus, Martin
    Dalewijk, Henk Jan
    Doering, Stephan
    Kaera, Andres
    Moran, Paul
    Renneberg, Babette
    Ribaudi, Joaquim Soler
    Taubner, Svenja
    Wilberg, Theresa
    Mehlum, Lars
    BORDERLINE PERSONALITY DISORDER AND EMOTION DYSREGULATION, 2019, 6 (1)
  • [35] Cell therapy for liver disorders: past, present and future
    Ortuno-Costela, M. Carmen
    Pinzani, Massimo
    Vallier, Ludovic
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2025, : 329 - 342
  • [36] WWOX-Related Neurodevelopmental Disorders: Models and Future Perspectives
    Steinberg, Daniel J.
    Aqeilan, Rami I.
    CELLS, 2021, 10 (11)
  • [37] Models of low vision care: past, present and future
    Ryan, Barbara
    CLINICAL AND EXPERIMENTAL OPTOMETRY, 2014, 97 (03) : 209 - 213
  • [38] The past, present, and future of computational models of cognitive development
    Schlesinger, Matthew
    McMurray, Bob
    COGNITIVE DEVELOPMENT, 2012, 27 (04) : 326 - 348
  • [39] Transgenic models of α-synuclein pathology -: Past, present, and future
    Hashimoto, M
    Rockenstein, E
    Masliah, E
    PARKINSON'S DISEASE: THE LIFE CYCLE OF THE DOPAMINE NEURON, 2003, 991 : 171 - 188
  • [40] Boards' strategic involvement models: past, present, and future
    Bozhinovska, Tihona
    Eftimov, Ljupcho
    STRATEGIC MANAGEMENT, 2023,